Skip to content
10-Q

Quarterly Report

INHIBRX, INC.

0001739614-24-000029

← back to feed
Filed
May 9, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · Apr 30, 2024 52.4M sh
Shares Diluted Q1 2024 · Mar 31, 2024 54.55M sh
Shares Diluted Q1 2024 · Mar 31, 2023 43.58M sh
Capex Q1 2024 · Mar 31, 2024 $1.12M
Capex Q1 2024 · Mar 31, 2023 $23K
Operating Cash Flow Q1 2024 · Mar 31, 2024 −$63.05M
Operating Cash Flow Q1 2024 · Mar 31, 2023 −$39.94M
Long Term Debt Q1 2024 · Mar 31, 2024 $204.58M
Long Term Debt Q1 2024 · Dec 31, 2023 $206.97M
Cash And Equivalents Q1 2024 · Mar 31, 2024 $252.48M
Cash And Equivalents Q1 2024 · Dec 31, 2023 $277.92M
Stockholders Equity Q1 2024 · Mar 31, 2024 $11.57M
Stockholders Equity Q1 2024 · Dec 31, 2023 $43.5M
Stockholders Equity Q1 2024 · Mar 31, 2023 $15.13M
Stockholders Equity Q1 2024 · Dec 31, 2022 $58.06M
Current Liabilities Q1 2024 · Mar 31, 2024 $71.87M
Current Liabilities Q1 2024 · Dec 31, 2023 $56.31M
Total Liabilities Q1 2024 · Mar 31, 2024 $277.01M
Total Liabilities Q1 2024 · Dec 31, 2023 $264.39M
Current Assets Q1 2024 · Mar 31, 2024 $274.54M
Current Assets Q1 2024 · Dec 31, 2023 $295.36M
Total Assets Q1 2024 · Mar 31, 2024 $288.58M
Total Assets Q1 2024 · Dec 31, 2023 $307.89M
Eps Diluted Q1 2024 · Mar 31, 2024 −$1.44
Eps Diluted Q1 2024 · Mar 31, 2023 −$1.12
Eps Basic Q1 2024 · Mar 31, 2024 −$1.44
Eps Basic Q1 2024 · Mar 31, 2023 −$1.12
Sga Expense Q1 2024 · Mar 31, 2024 $9.97M
Sga Expense Q1 2024 · Mar 31, 2023 $6.4M
Rd Expense Q1 2024 · Mar 31, 2024 $63.85M
Rd Expense Q1 2024 · Mar 31, 2023 $37.39M
Net Income Q1 2024 · Mar 31, 2024 −$78.71M
Net Income Q1 2024 · Mar 31, 2023 −$48.92M
Operating Income Q1 2024 · Mar 31, 2024 −$73.83M
Operating Income Q1 2024 · Mar 31, 2023 −$43.77M
Revenue Q1 2024 · Mar 31, 2024 $0
Revenue Q1 2024 · Mar 31, 2023 $17K